Dutch guidelines for PrEP use now available
29 September 2016
Guidelines are now available for healthcare providers in the Netherlands on the appropriate use of the HIV prevention pill, PrEP (pre-exposure prophylaxis). The drug, Truvada, has been registered in Europe since August 2016 as an effective prevention against HIV infection, meaning that physicians in the Netherlands can now prescribe PrEP. The national guidelines, an intiative driven by the Dutch association of HIV treating physicians (NVHB) in collaboration with all relevant partners, offer advice on who will benefit from the use of PrEP, how PrEP should be taken, and how to support people who use PrEP.